IPS Therapeutique (IPST) is a Contract Research Organization dedicated to the preclinical evaluation of the efficacy and safety of new drugs using validated and highly predictive models. Established in 1999, we have conducted more than 3,000 preclinical cardiac safety and efficacy studies and over 120 GLP-compliant studies in support of FDA, EMEA, Health Canada and MoHW.